|   临床分型  |       
  |       
  |       
  |       
  |    
|   危重型患者[例(%)]  |       12 (92.3)  |       6 (40.0)  |       -  |       0.006  |    
|   重型患者[例(%)]  |       1 (7.7)  |       9 (60.0)  |       -  |       
  |    
|   发病至就诊时间(天)  |       8.62 ± 4.17  |       6.13 ± 3.02  |       1.82  |       0.080  |    
|   发病症状[例(%)]  |       
  |       
  |       
  |       
  |    
|   发热  |       13 (100)  |       14 (93.3)  |       -  |       1.000  |    
|   咳嗽  |       11 (84.6)  |       13 (86.7)  |       -  |       1.000  |    
|   气促  |       11 (84.6)  |       14 (93.3)  |       -  |       0.583  |    
|   乏力  |       3 (23.1)  |       5 (33.3)  |       -  |       0.686  |    
|   腹泻  |       0 (0.0)  |       0 (0.0)  |       -  |       -  |    
|   基础疾病[例(%)]  |       
  |       
  |       
  |       
  |    
|   高血压  |       5 (38.5)  |       6 (40.0)  |       -  |       1.000  |    
|   冠心病  |       2 (15.4)  |       1 (6.7)  |       -  |       0.583  |    
|   糖尿病  |       6 (46.2)  |       1 (6.7)  |       -  |       0.029  |    
|   慢性肾衰竭  |       3 (23.1)  |       0 (0.0)  |       -  |       0.087  |    
|   器官功能损伤[例(%)]  |       
  |       
  |       
  |       
  |    
|   肝功损害  |       8 (61.5)  |       7 (46.7)  |       -  |       0.476  |    
|   心肌损害  |       4 (30.8)  |       4 (26.7)  |       -  |       1.000  |    
|   休克  |       1 (7.7)  |       2 (13.3)  |       -  |       1.000  |    
|   细胞免疫缺陷  |       13 (100)  |       12 (80.0)  |       -  |       0.226  |    
|   病情评分  |       
  |       
  |       
  |       
  |    
|   APACHE II评分(分)  |       11.2 ± 6.7  |       11.7 ± 6.1  |       −0.241  |       0.812  |    
|   SOFA 评分(分)  |       3.0 (2.0, 5.0)  |       3.0 (2.0, 4.0)  |       −0.165  |       0.869  |    
|   实验室检查指标  |       
  |       
  |       
  |       
  |    
|   氧合指数(mmhg)  |       222.5 ± 54.6  |       232.7 ± 61.1  |       −0.462  |       0.648  |    
|   中性粒细胞率(%)  |       83.0 ± 8.0  |       75.0 ± 9.0  |       2.509  |       0.019  |    
|   淋巴细胞计数(×109/L)  |       0.70 ± 0.45  |       1.06 ± 0.47  |       −2.062  |       0.049  |    
|   C-反应蛋白(mg/L)  |       52.05 ± 38.86  |       45.04 ± 43.74  |       0.445  |       0.660  |    
|   CD3细胞计数(个/mL)  |       429.38 ± 309.27  |       534.14 ± 270.70  |       −0.938  |       0.357  |    
|   CD4/CD8 (%)  |       1.53 ± 1.34  |       1.68 ± 0.50  |       −0.368  |       0.718  |    
|   乳酸脱氢酶(U/L)  |       333.15 ± 130.04  |       325.60 ± 100.09  |       0.174  |       0.864  |    
|   血清铁蛋白(ng/mL)  |       484.03 ± 356.05  |       376.07 ± 147.17  |       1.020  |       0.323  |    
|   白细胞计数(×109/L)  |       7.54 (4.20, 10.67)  |       5.86 (4.63, 8.45)  |       −0.852  |       0.394  |    
|   CD4细胞计数(个/mL)  |       159.0 (86.0, 357.5)  |       274.0 (165.3, 445.0)  |       −1.068  |       0.286  |    
|   CD8细胞计数(个/mL)  |       106.0 (78.0, 201.0)  |       218.0 (88.0, 251.5)  |       −0.704  |       0.482  |    
|   空腹血糖(mmol/L)  |       10.75 (8.22, 13.46)  |       5.76 (5.66, 7.21)  |       −3.478  |       0.001  |    
|   D-二聚体(ug/ml)  |       1.52 (1.08, 2.02)  |       0.79 (0.59, 1.28)  |       −2.234  |       0.025  |    
|   病毒转阴时间(天)  |       32.0 ± 4.0  |       16.0 ± 3.0  |       11.067  |       <0.001  |    
|   糖化血红蛋白(%)  |       6.02 ± 0.792  |       5.38 ± 0.843  |       1.736  |       0.385  |